Galera Therapeutics, Inc.
Recent Filings
All 325 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Sorensen Mel | President and CEO | Sale | 70,000 @ $0.02 | 195,029 | Nov 20, 2025 |
| CHANG NANCY T | — | Purchase | 7,644,932 @ $0.07 | 7,644,932 | Dec 30, 2024 |
| Sorensen Mel | President and CEO | Sale | 67,015 @ $0.07 | 265,029 | Aug 16, 2024 |
| Schneid Yair | — | Purchase | 4,245 @ $0.20 | 10,645,066 | Apr 18, 2024 |
| Altamont Pharmaceutical Holdings, LLC | — | Sale | 400,000 @ $0.23 | 4,880,000 | Mar 28, 2024 |
| Schneid Yair | — | Purchase | 150,000 @ $0.18 | 7,260,801 | Feb 7, 2024 |
| Bachleda Mark | Chief Commercial Officer | Purchase | 11,000 @ $2.25 | 11,000 | Mar 16, 2023 |
| Degnan Chris | Chief Financial Officer | Purchase | 10,000 @ $1.96 | 10,000 | Mar 13, 2023 |
| Sorensen Mel | President and CEO | Purchase | 100,000 @ $1.68 | 332,044 | Mar 10, 2023 |
| West Linda | — | Purchase | 20,000 @ $2.74 | 60,000 | Dec 17, 2021 |